BACKGROUND: Preoperative magnetic resonance imaging (MRI) is increasingly used in the workup of breast cancer patients and could lead to changes in surgical management. It is unclear how the information gained from MRI studies affects surgical decision making and influences clinical outcomes. These issues are addressed in this review. METHODS: PubMed database searches were performed to retrieve and analyze respective original research and review articles on preoperative MRI in the evaluation of breast cancer patients. RESULTS: Preoperative MRI is a highly sensitive but nonspecific method that leads to changes in surgical management with increased numbers of more extended surgical interventions. It appears that a relatively large proportion of MRI-driven changes in surgical management result in overtreatment without conclusively proven beneficial effects on such clinical outcomes as decrease in reoperation rates or improved patient survival. CONCLUSIONS: Thus, routine use of supplementary preoperative breast MRI should be discouraged until compelling evidence of its effectiveness is available.
BACKGROUND: Preoperative magnetic resonance imaging (MRI) is increasingly used in the workup of breast cancerpatients and could lead to changes in surgical management. It is unclear how the information gained from MRI studies affects surgical decision making and influences clinical outcomes. These issues are addressed in this review. METHODS: PubMed database searches were performed to retrieve and analyze respective original research and review articles on preoperative MRI in the evaluation of breast cancerpatients. RESULTS: Preoperative MRI is a highly sensitive but nonspecific method that leads to changes in surgical management with increased numbers of more extended surgical interventions. It appears that a relatively large proportion of MRI-driven changes in surgical management result in overtreatment without conclusively proven beneficial effects on such clinical outcomes as decrease in reoperation rates or improved patient survival. CONCLUSIONS: Thus, routine use of supplementary preoperative breast MRI should be discouraged until compelling evidence of its effectiveness is available.
Authors: Cameron D Adkisson; Laura A Vallow; Kristin Kowalchik; Rebecca McNeil; Stephanie Hines; Elizabeth Deperi; Alvaro Moreno; Vivek Roy; Edith A Perez; Sarah A McLaughlin Journal: Ann Surg Oncol Date: 2011-01-05 Impact factor: 5.344
Authors: J Heil; A Buehler; M Golatta; J Rom; A Schipp; A Harcos; A Schneeweiss; G Rauch; C Sohn; H Junkermann Journal: Ann Oncol Date: 2011-04-02 Impact factor: 32.976
Authors: R M Mann; C E Loo; T Wobbes; P Bult; J O Barentsz; K G A Gilhuijs; C Boetes Journal: Breast Cancer Res Treat Date: 2010-01 Impact factor: 4.872
Authors: K Schelfout; M Van Goethem; E Kersschot; C Colpaert; A M Schelfhout; P Leyman; I Verslegers; I Biltjes; J Van Den Haute; J P Gillardin; W Tjalma; J C Van Der Auwera; P Buytaert; A De Schepper Journal: Eur J Surg Oncol Date: 2004-06 Impact factor: 4.424
Authors: Stephane Zervoudis; George Iatrakis; Eirini Tomara; Anastasia Bothou; George Papadopoulos; George Tsakiris Journal: World J Clin Oncol Date: 2014-08-10
Authors: Santo Maimone; Andrey P Morozov; Zhuo Li; Emily C Craver; Erin A Elder; Sarah A McLaughlin Journal: Ann Surg Oncol Date: 2022-03-08 Impact factor: 5.344
Authors: Braden Miller; Hunter Chalfant; Alexandra Thomas; Elizabeth Wellberg; Christina Henson; Molly W McNally; William E Grizzle; Ajay Jain; Lacey R McNally Journal: Int J Mol Sci Date: 2021-03-09 Impact factor: 5.923